253 related articles for article (PubMed ID: 18166628)
1. The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.
Pipinos II; Judge AR; Selsby JT; Zhu Z; Swanson SA; Nella AA; Dodd SL
Vasc Endovascular Surg; 2007 Dec-2008 Jan; 41(6):481-9. PubMed ID: 18166628
[TBL] [Abstract][Full Text] [Related]
2. The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.
Pipinos II; Judge AR; Selsby JT; Zhu Z; Swanson SA; Nella AA; Dodd SL
Vasc Endovascular Surg; 2008; 42(2):101-12. PubMed ID: 18390972
[TBL] [Abstract][Full Text] [Related]
3. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease.
Brass EP; Hiatt WR
Vasc Med; 2000; 5(1):55-9. PubMed ID: 10737157
[TBL] [Abstract][Full Text] [Related]
4. Mitochondriopathy of peripheral arterial disease.
Makris KI; Nella AA; Zhu Z; Swanson SA; Casale GP; Gutti TL; Judge AR; Pipinos II
Vascular; 2007; 15(6):336-43. PubMed ID: 18053417
[TBL] [Abstract][Full Text] [Related]
5. High-energy phosphate metabolism in the exercising muscle of patients with peripheral arterial disease.
Schocke M; Esterhammer R; Greiner A
Vasa; 2008 Aug; 37(3):199-210. PubMed ID: 18690587
[TBL] [Abstract][Full Text] [Related]
6. Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.
Paradis S; Charles AL; Meyer A; Lejay A; Scholey JW; Chakfé N; Zoll J; Geny B
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C968-82. PubMed ID: 27076618
[TBL] [Abstract][Full Text] [Related]
7. Diet-induced obesity augments ischemic myopathy and functional decline in a murine model of peripheral artery disease.
Fletcher E; Miserlis D; Sorokolet K; Wilburn D; Bradley C; Papoutsi E; Wilkinson T; Ring A; Ferrer L; Haynatzki G; Smith RS; Bohannon WT; Koutakis P
Transl Res; 2023 Oct; 260():17-31. PubMed ID: 37220835
[TBL] [Abstract][Full Text] [Related]
8. Increased skeletal muscle mitochondrial free radical production in peripheral arterial disease despite preserved mitochondrial respiratory capacity.
Hart CR; Layec G; Trinity JD; Kwon OS; Zhao J; Reese VR; Gifford JR; Richardson RS
Exp Physiol; 2018 Jun; 103(6):838-850. PubMed ID: 29604234
[TBL] [Abstract][Full Text] [Related]
9. [Mitochondrial diseases. Diagnostic light and electron microscopic changes in muscle biopsies from patients with mitochondrial myopathy].
Lindal S; Lund I; Borud O; Torbergsen T; Aasly J; Mellgren SI
Tidsskr Nor Laegeforen; 1991 Jan; 111(2):202-6. PubMed ID: 1998182
[TBL] [Abstract][Full Text] [Related]
10. Targeted Expression of Catalase to Mitochondria Protects Against Ischemic Myopathy in High-Fat Diet-Fed Mice.
Ryan TE; Schmidt CA; Green TD; Spangenburg EE; Neufer PD; McClung JM
Diabetes; 2016 Sep; 65(9):2553-68. PubMed ID: 27284110
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease.
Hiatt WR; Wolfel EE; Regensteiner JG; Brass EP
J Appl Physiol (1985); 1992 Jul; 73(1):346-53. PubMed ID: 1506390
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle dysfunction is associated with derangements in mitochondrial bioenergetics (but not UCP3) in a rodent model of sepsis.
Zolfaghari PS; Carré JE; Parker N; Curtin NA; Duchen MR; Singer M
Am J Physiol Endocrinol Metab; 2015 May; 308(9):E713-25. PubMed ID: 25714676
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Structure and Function in the Metabolic Myopathy Accompanying Patients with Critical Limb Ischemia.
Groennebaek T; Billeskov TB; Schytz CT; Jespersen NR; Bøtker HE; Olsen RKJ; Eldrup N; Nielsen J; Farup J; De Paoli FV; Vissing K
Cells; 2020 Feb; 9(3):. PubMed ID: 32121096
[TBL] [Abstract][Full Text] [Related]
14. Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage.
Pipinos II; Swanson SA; Zhu Z; Nella AA; Weiss DJ; Gutti TL; McComb RD; Baxter BT; Lynch TG; Casale GP
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R290-6. PubMed ID: 18480238
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle mitochondria in health and disease.
De Mario A; Gherardi G; Rizzuto R; Mammucari C
Cell Calcium; 2021 Mar; 94():102357. PubMed ID: 33550207
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial myopathy with diffuse activation and focal deficiency of mitochondrial ATPase and carnitine deficiency.
Müller-Höcker J; Paetzke I; Pongratz D; Hübner G
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(2):185-96. PubMed ID: 2859691
[TBL] [Abstract][Full Text] [Related]
17. Statins Affect Skeletal Muscle Performance: Evidence for Disturbances in Energy Metabolism.
Allard NAE; Schirris TJJ; Verheggen RJ; Russel FGM; Rodenburg RJ; Smeitink JAM; Thompson PD; Hopman MTE; Timmers S
J Clin Endocrinol Metab; 2018 Jan; 103(1):75-84. PubMed ID: 29040646
[TBL] [Abstract][Full Text] [Related]
18. Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease.
Thome T; Kumar RA; Burke SK; Khattri RB; Salyers ZR; Kelley RC; Coleman MD; Christou DD; Hepple RT; Scali ST; Ferreira LF; Ryan TE
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290279
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion.
Xu H; Wang Z; Zheng L; Zhang W; Lv H; Jin S; Yuan Y
J Clin Pathol; 2014 Nov; 67(11):999-1005. PubMed ID: 25190818
[TBL] [Abstract][Full Text] [Related]
20. Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review.
McDermott MM; Ferrucci L; Gonzalez-Freire M; Kosmac K; Leeuwenburgh C; Peterson CA; Saini S; Sufit R
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2577-2585. PubMed ID: 32938218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
